So Chak-Yu, Kang Guson, Lee James C, Frisoli Tiberio M, O'Neill Brian, Wang Dee Dee, Eng Marvin H, O'Neill William, Villablanca Pedro A
Center for Structural Heart Disease, Henry Ford Hospital, Detroit, MI, USA; Divison of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, SAR, China.
Center for Structural Heart Disease, Henry Ford Hospital, Detroit, MI, USA.
Cardiovasc Revasc Med. 2022 Dec;45:44-50. doi: 10.1016/j.carrev.2022.07.003. Epub 2022 Jul 11.
Acute MR due to mechanical mitral valve (MV) complications frequently results in cardiogenic shock and requires emergency surgical intervention. There was limited evidence for alternative treatment like MitraClip for patients at prohibitive surgical risk. We aimed to study the technical features and outcomes of emergency transcatheter edge-to-edge repair (TEER) using the MitraClip system for patients with cardiogenic shock (CS) secondary to acute mitral regurgitation (MR) and mechanical MV complication.
We performed institutional review and systemic literature review to identify all TEER for CS patients due to acute mitral regurgitation and mechanical MV complication. Clinical endpoints included device success rate assessed at the end of procedure, ability to wean off MCS, all-cause and cardiovascular mortality at 30-day.
Eight patients were identified from institutional review. Detail anatomical analysis found that patients with mechanical MV complications related to myocardial infarction had a lower transseptal height achieved during MitraClip (3.6 ± 0.1 cm vs 4.3 ± 0.3 cm, p = 0.03) than those not related. Pooled analysis for cases from institutional review (n = 8) and systemic literature review (n = 16) was performed. The device success rate was 68.8 %. Seventy-five percent (n = 18) cases required mechanical circulatory support (MCS), and 94.4 % were able to wean off MCS. At 30-day, the cardiovascular mortality was 4.5 % and the all-cause mortality was 9.1 %.
In CS patients due to acute MR and mechanical MV complications, TEER with/without MCS was feasible with a reasonable device success rate.
机械性二尖瓣(MV)并发症导致的急性二尖瓣反流(MR)常引发心源性休克,需要紧急手术干预。对于手术风险极高的患者,像MitraClip这样的替代治疗方法的证据有限。我们旨在研究使用MitraClip系统对继发于急性二尖瓣反流(MR)和机械性MV并发症的心源性休克(CS)患者进行紧急经导管缘对缘修复(TEER)的技术特点和疗效。
我们进行了机构回顾和系统文献回顾,以确定所有因急性二尖瓣反流和机械性MV并发症而接受TEER的CS患者。临床终点包括手术结束时评估的器械成功率、脱离机械循环支持(MCS)的能力、30天时的全因死亡率和心血管死亡率。
通过机构回顾确定了8例患者。详细的解剖分析发现,与心肌梗死相关的机械性MV并发症患者在使用MitraClip期间实现的经房间隔高度(3.6±0.1厘米对4.3±0.3厘米,p = 0.03)低于无相关并发症的患者。对机构回顾中的病例(n = 8)和系统文献回顾中的病例(n = 16)进行了汇总分析。器械成功率为68.8%。75%(n = 18)的病例需要机械循环支持(MCS),94.4%的患者能够脱离MCS。在30天时,心血管死亡率为4.5%,全因死亡率为9.1%。
对于因急性MR和机械性MV并发症导致的CS患者,无论是否使用MCS,TEER都是可行的,器械成功率合理。